Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  United Therapeutics Corporation    UTHR

Delayed Quote. Delayed  - 05/06 04:39:10 pm
105.92 USD   -1.72%
04/28 UNITED THERAPEU : beats 1Q profit forecasts
04/28 UNITED THERAPEU : Announces Executive Leadership Changes
04/28 UNITED THERAPEU : Reports First Quarter 2016 Financial Results
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo United Therapeutics Corpor
Develops pharmaceutical products

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening cardiovascular and infectious diseases and cancer.

The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Number of employees : 750 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceutical1,289100%1,466100% +13.76%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States1,18191.6%1,35392.3% +14.59%
Rest-of-World107.768.4%112.767.7% +4.64%
Managers
NameAgeSinceTitle
Martine A. Rothblatt PhD, MBA611996Chairman & Co-Chief Executive Officer
Roger A. Jeffs, PhD551998President, Co-Chief Executive Officer & Director
David Zaccardelli, PhD512004Chief Operating Officer & Executive Vice President
James Christopher Edgemond482013Chief Financial Officer & Treasurer
Raymond C. Kurzweil, PhD672002Independent Director
Louis Wade Sullivan, MD812013Independent Director
Raymond Allen Dwek732002Non-Independent Director
Christopher Patusky512002Vice Chairman
Christopher Causey, MBA522003Independent Director
Richard Giltner512009Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 68,828,264 43,885,753 63.8% 24,206,276 35.2% 63.8%
Shareholders
NameEquities%
Fidelity Management & Research Co. 4,411,369 9.73%
BlackRock Fund Advisors 3,784,673 8.34%
The Vanguard Group, Inc. 3,357,551 7.40%
Scopia Capital Management LP 2,848,583 6.28%
AQR Capital Management LLC 1,788,772 3.94%
SSgA Funds Management, Inc. 1,740,886 3.84%
Palo Alto Investors LLC 1,518,654 3.35%
AJO LP 1,480,935 3.27%
BlackRock Advisors LLC 1,361,399 3.00%
BlackRock Investment Management LLC 1,219,996 2.69%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
CELLTRION, INC.
LONZA GROUP AG
QUINTILES TRANSNA..
ALKERMES PLC
QIAGEN NV
ALNYLAM PHARMACEU..
UNITED THERAPEUTI..
SEATTLE GENETICS,..
IONIS PHARMACEUTI..
CHARLES RIVER LAB..
BIO-TECHNE CORP
ICON PLC
PAREXEL INTERNATI..
ACADIA PHARMACEUT..
BB BIOTECH AG
-
INTREXON CORP
PRA HEALTH SCIENC..
ANACOR PHARMACEUT..
LIGAND PHARMACEUT..
Sector Biotechnology & Medical Research
United Therapeutics Corpor : Connections
Medical Learning Co., Inc.
University of Oxford
FatKat, Inc.
Kurzweil Technologies, Inc.
Synthetic Genomics, Inc.
Patusky Associates LLC
Project HOPE-The-People-To-People HealthFoundation, Inc.
America's Public Television Stations
X PRIZE Foundation
Google, Inc.
Morehouse School of Medicine
The Sullivan Alliance
Oxford Glycobiology Institute
Public Broadcasting Atlanta
Slater Run Vineyards LLC
The National Health Museum
Causey Consortium
Company contact information
United Therapeutics Corp.
1040 Spring Street
Silver Spring, MD 20910

Phone : +1.301.608.9292
Fax : +1.301.608.9291
Web : www.unither.com
© 2016 People , Fundamentals and Ownership